参考文献/References:
[1] PHADKE S R, PURI R D, RANGANATH P. Prenatal screening for genetic disorders: Suggested guidelines for the Indian Scenario[J]. The Indian Journal of Medical Research, 2017, 146(6): 689-699.
[2] TU S, ROSENTHAL M, WANG D, et al. Performance of prenatal screening using maternal serum and ultrasound markers for Down syndrome in Chinese women: a systematic review and meta-analysis[J]. BJOG-An International Journal of Obstetrics and Gynaecology, 2016, 123(3): 12-22.
[3] KAGAN K O, SONEK J, WAGNER P, et al. Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnor-malities[J]. Archives of Gynecology and Obstetrics, 2017, 296(4): 645-651.
[4] ZHANG Xiaoyan, WANG Wei, HE Falin, et al. Proficiency testing of maternal serum prenatal screening in second trimester in China,2015[J]. Biochemia Medica, 2017, 27(1): 114-121.
[5] MANOTAYA S, ZITZLER J, LI Xiaotian, et al. Effect of ethnicity on .rst trimester biomarkers for combined trisomy 21 screening: Results from a multicenter study in six Asian countries[J]. Prenatal Diagnosis, 2015, 35(8): 735-740.
[6] LERTHIRANWONG T, WANAPIRAK C, SIR-ICHOTIYAKUL S, et al. Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome[J]. The Journal of Ma-ternal-fetal & Neonatal Medicine, 2018, 31(21): 2847-2851.
[7] HE Falin, WANG Wei,ZHONG Kun, et al. The status of quality control investigation and analysis for maternal serum marker of prenatal screening laboratories in China[J]. Clinical Laboratory, 2017, 63(1): 183-188.
[8] LONG Yao, LIU Yanqiu, MA Pengpeng, et al. Establishment of medians for maternal serum markers in Down’s syndrome screening during the second trimester of pregnancy in north-central region of Jiangxi Province[J]. Journal of Central South University(Medical Sciences), 2017, 42(7): 831-835.
[9] LI Yahong, ZHANG Xiaojuan, HONG Dongyang, et al. Signi.cance of data analysis in the quality control of prenatal screening for Down syndrome[J]. Biomedical Reports, 2018, 8(5): 447-453.
[10] 燕凤，燕飞，姚念玲，等．孕妇外周血无创 DNA检测技术在产前诊断中的应用 [J]．现代检验医学杂志 , 2019, 34(1):17-21. YAN Feng,YAN Fei,YAO Nianling, et al. Application of non-invasive DNA detection technique in maternal peripheral blood for prenatal diagnosis[J]. Journal of Modern Laboratory Medicine,2019,34(1):17-21.
[11] QUIBEL T, ROZENBERG P. What are the real purpose and scope of screening for aneuploidy[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(2): 124-129.
[12] QI Qingwei, LU Sijia, ZHOU Xiya, et al. Copy number variation sequencing-based prenatal diagnosis using cell-free fetal DNA in amniotic fluid[J]. Prenatal Diagnosis, 2016, 36(6): 576-583.
[13] LINDQUIST A, POULTON A, HALLIDAY J, et al. Prenatal diagnostic testing and atypical chromosome abnormalities following combined first-trimester screening: implications for contingent models of non-invasive prenatal testing[J]. Ultrasound in Obstetrics & Gynecology, 2018, 51(4): 487-492.
[14] XU Zunpeng, LI Bei, LIAO Can, et al. Results of prena-tal screening for fetal chromosome abnormality during the first trimester pregnancy in Guangzhou[J]. Chinese Journal of Medical Genetics, 2014, 31(5): 632-635.
[15] 梁培松，王结珍，陈康，等．孕早期年龄 ,BMI和 PAPPA水平综合评价对 GDM的预测价值 [J]．现代检验医学杂志 , 2020, 35(1):133-135. LIANG Peisong,WANG Jiezhen,CHEN Kang,et al. Predictive value of comprehensive evaluation of early pregnant age, BMI and PAPPA levels to the GDM[J]. Journal of Modern Laboratory Medicine, 2020，35(1): 133-135.
[16] GOMES M S, CARLOS-ALVES M, TROCADO V, et al. Prediction of adverse pregnancy outcomes by extreme values of .rst trimester screening markers[J]. Obstetric Medicine, 2017, 10(3): 132-137.
[17] ALMOHAMADY A M G A F, SHERIF M, RASLANA N A, et al. Could .rst-trimester assessment of placental functions predict preeclampsia and intrauterine growth restriction? A prospective cohort study[J]. The Journal of Maternal - Fetal & Neonatal Medicine, 2016, 29(3):413-417.
[18] BOUZID A, AYACHI A, DHAOUDI H, et al.Relevance of first trimester serum markers to predict pregnancy complications: A tunisian preliminary study[J]. Gynecologie Obstetrique & Fertilite, 2016, 44(2): 96-100.
[19] KHAMBALIA A Z, ROBERTS C L, MORRIS J ,et al. Maternal body weight and .rst trimester screening for chromosomal anomalies[J].Australian and New Zealand Journal of Obstetrics and Gynaecology,2014, 54(5):490-492.
[20] HASEGAWA J, WADA S,KASAMATSU A, et al.Distribution of PAPP-A and total hCG between 11 and 13 weeks of gestation in japanese pregnant women[J].J Matern Fetal Neonatal Med, 2020, 33(12): 2017-2022.
相似文献/References:
[1]余成强,李步荣,何家花,等.陕西省商洛地区孕早期妇女甲状腺功能参考范围的初步建立和应用研究[J].现代检验医学杂志,2020,35(02):139.[doi:10.3969/j.issn.1671-7414.2020.02.038]
YU Cheng-qiang,LI Bu-rong,HE Jia-hua,et al.Preliminary Study on Thyroid Function Reference Ranges of PregnantWomen During Early Pregnancy in Shangluo[J].Journal of Modern Laboratory Medicine,2020,35(01):139.[doi:10.3969/j.issn.1671-7414.2020.02.038]
[2]匡梦华,卢 聪,匡梦娇.孕早期基于多因素回归分析构建妊娠期糖尿病预测模型及验证[J].现代检验医学杂志,2024,39(01):158.[doi:10.3969/j.issn.1671-7414.2024.01.029]
KUANG Menghua,LU Cong,KUANG Mengjiao.Construction and Validation of Prediction Model of Gestational Diabetes Mellitus Based on Multivariate Regression Analysis in the First Trimester of Pregnancy[J].Journal of Modern Laboratory Medicine,2024,39(01):158.[doi:10.3969/j.issn.1671-7414.2024.01.029]